Relationship between Concentrations of
Lutein and StARD3 among Pediatric and
Geriatric Human Brain Tissue by Tanprasertsuk, Jirayu et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Nutrition and Health Sciences -- Faculty
Publications Nutrition and Health Sciences, Department of
2016
Relationship between Concentrations of Lutein
and StARD3 among Pediatric and Geriatric
Human Brain Tissue
Jirayu Tanprasertsuk
Binxing Li
Paul S. Bernstein
Rohini Vishwanathan
Mary Ann Johnson
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/nutritionfacpub
Part of the Human and Clinical Nutrition Commons, Molecular, Genetic, and Biochemical
Nutrition Commons, and the Other Nutrition Commons
This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health Sciences -- Faculty Publications by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.
Authors
Jirayu Tanprasertsuk, Binxing Li, Paul S. Bernstein, Rohini Vishwanathan, Mary Ann Johnson, Leonard Poon,
and Elizabeth J. Johnson
RESEARCH ARTICLE
Relationship between Concentrations of
Lutein and StARD3 among Pediatric and
Geriatric Human Brain Tissue
Jirayu Tanprasertsuk1, Binxing Li2, Paul S. Bernstein2, Rohini Vishwanathan1, Mary
Ann Johnson3, Leonard Poon3, Elizabeth J. Johnson1*
1 Jean Mayer USDA Human Nutrition, Research Center on Aging at Tufts University, Boston, MA, 02111,
United States of America, 2 Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT,
84132, United States of America, 3 Institute of Gerontology, University of Georgia, Athens, GA, 30602,
United States of America
* elizabeth.johnson@tufts.edu
Abstract
Lutein, a dietary carotenoid, selectively accumulates in human retina and brain. While many
epidemiological studies show evidence of a relationship between lutein status and cognitive
health, lutein’s selective uptake in human brain tissue and its potential function in early neural
development and cognitive health have been poorly evaluated at a molecular level. The
objective of this study was to evaluate the cross-sectional relationship between concentra-
tions of brain lutein and StARD3 (identified as its binding protein in retinal tissue) among three
age groups: infants (1–4 months, n = 10), older adults (55–86 years, n = 8), and centenarians
(98–105 years, n = 10). Brain lutein concentrations were analyzed by high-performance liquid
chromatography and StARD3 levels were analyzed byWestern Blot analysis. The strong
relationship in infant brains (r = 0.75, P < 0.001) suggests that lutein has a role in neural devel-
opment. The relationship remained significant but weaker in older adults (r = 0.51, P < 0.05)
and insignificant in centenarians (r = 0.08, P > 0.05), seven of whom had mild cognitive
impairment (MCI) or dementia. These exploratory findings suggest an age-related decrease
or abnormality of StARD3 activity in human brain. Given that StARD3 is also involved in cho-
lesterol transportation, a process that is aberrant in neurodegenerative diseases, the potential
protective function of lutein against these diseases remains to be explored.
Introduction
Carotenoids are naturally occurring plant pigments which are commonly found in the diet. Of
the 40 carotenoids found in common foods in the US, about 25 are measurable in human
serum, tissues and milk, but only 2 carotenoids, lutein and zeaxanthin, cross the blood-retina
barrier to form the macular pigment in the human retina [1][2]. The preferential accumulation
of these two oxygenated carotenoids, also known as xanthophylls, in human retina can be
explained by identification of three retinal carotenoid-binding proteins: 1) a lutein-binding
protein, steroidogenic acute regulatory domain 3 (StARD3), 2) a zeaxanthin-binding protein,
glutathione S-transferase P1, and 3) tubulin, which serves as a site for high capacity deposition
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StARD3, previously known as MLN64, was first identified in malignant breast cancer [6]. King
et al. found that StARD3 was also produced in glia and neurons in specific regions of human
brain [7]. StARD3 is an integral membrane protein which resides in late endosome and lyso-
some organelles and is proposed to be involved in intracellular lipid (e.g. cholesterol) traffick-
ing. This may be important in relation to cognitive function given that aberrations of
cholesterol transport in brain are often linked to processes of aging and onset of neurodegener-
ative disorders including Alzheimer's disease [8].
Similar to the retina, lutein is also the predominant carotenoid in human brain tissue in
early and late life [9–11]. While it accounts for 31% of total brain carotenoids in adults [10],
lutein accounts for approximately 59% of total brain carotenoids in infants even with a brief
exposure to a diet typically low in lutein [9]. We have reported that lutein and zeaxanthin in
the macula are highly correlated with their concentrations in the brain [11][12]. Thus, macular
pigment density likely reflects lutein and zeaxanthin brain concentrations. This may explain
the epidemiological evidence of significant relationships between macular pigment density and
cognitive health in three cross-sectional studies [13–15]. We have also reported that among the
carotenoids, brain concentrations of lutein from autopsy specimens in older adults were most
consistently related to pre-mortem measures of global cognition [10].
In order to better understand a possible role of lutein in cognitive function throughout the
lifespan, a better biochemical understanding of the selective uptake of lutein in human brain
tissue is needed. Therefore, the objective of this study is to evaluate the cross-sectional relation-
ship between the concentration of lutein and StARD3 in brain tissue from infant, older adult
and very old adult decedents.
Materials and Methods
Subjects
Voluntarily donated brain tissues from decedents from three age groups were studied: infants
(1–4 months), older adults (55–86 years), and centenarians (98–105 years). Samples came
from a subset of three studies previously published, and their characteristics have been previ-
ously described [9–11] and were obtained from the National Institute of Child Health &
Human Development Brain & Tissue Bank for Developmental Disorders, University of Mary-
land (infants) (http://medscholl.umaryland.edu/btbank/), the National Disease Research Inter-
change, National Resource Center (older adults) and the Georgia Centenarian Study
(centenarians). Tissues were obtained from various regions of the brain, which included hippo-
campus (Hipp), temporal (TC), frontal (FC), and occipital (OC) cortices. It is noteworthy that
these regions of the brain are associated with memory (Hipp), auditory perception (TC), execu-
tive function (FC), and vision (OC). A total of seventeen tissues were obtained from infant
decedents. Both FC and Hipp tissues were available from seven infant decedents, while three
infant decedents provided only FC tissue. For older adults, each of eight decedents provided
one OC tissue and one Hipp tissue, hence a total of sixteen tissues. Each of five centenarians
provided both FC and TC tissues, while only FC tissue was acquired from four centenarians
and only TC tissue from one centenarian. Tissues were identified using a unique numerical
identifier which obscured the identity of the decedent. Tissues (~0.5 g) were stored at -70°C
until analysis for carotenoids.
Brain Carotenoid Extraction
The brain extraction procedure was adapted from Park et al [16]. The detailed extraction pro-
cedure has been described in the previous publication by Vishwanathan et al [12].
Lutein and StARD3
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Carotenoid Analysis by High Performance Liquid Chromatography
Brain extracts were analyzed using reverse-phase high performance liquid chromatography.
Twenty microliters of the brain extract were injected onto a C30 carotenoid column (3 μm,
150 × 4.6 mm, YMC, Wilmington, NC). The method was described by Yeum et al. in detail
[17]. The lower limit of detection is 0.2 pmol for carotenoids.
StARD3Western Blot Analysis
The brain tissues were homogenized in 10 mM Tris-HCl buffer (pH7.4) containing 0.2 mM
PMSF and 10 μg/mL aprotinin to prepare total protein extracts. Proteins were separated on
4–15% gradient SDS–PAGE and transferred to 0.45 μm nitrocellulose membranes using a
trans-blot SD semi-dry transfer cell (Bio-Rad, Hercules, CA) at 20 V for 1 h. Nonspecific bind-
ing was blocked by immersing the membrane in 5% (w/v) nonfat dried milk in 0.01% (v/v)
Tween 20 in TBS for 1 h at room temperature on an orbital shaker. The membranes were
rinsed briefly with two changes of TBS and incubated with primary antibody overnight. Pri-
mary antibody to StARD3 (rabbit polyclonal antibody, N-62 StAR) was a gift from Professor
Walter L. Miller at the University of California—San Francisco, with a 1:5000 dilution ratio.
After two changes of wash buffer, the membranes were incubated with goat anti-rabbit IgG (H
+L)-HRP conjugate secondary antibody (1:1000) for 2 h at room temperature. To visualize
bands, membranes were developed using ECL Plus Western blot detection reagents (Amer-
sham Biosciences, Pittsburgh, PA). Images of western blots were captured by FluorChemQ gel
image system, and the intensity of the bands was measured by AlphaView Q (Cell Bioscience
Inc., CA).
Statistical Analysis
Given the novelty of this work, no sample size calculations were feasible. Data are expressed
as means ± SEM. Concentrations of cis- and trans-lutein were combined to yield total lutein
concentrations. Band intensity of StARD3 measured by AlphaView Q (Cell Bioscience Inc.,
CA) was used to represent level of StARD3 from brain tissues. Differences in age between
sexes among each age group were assessed using Wilcoxon rank sum test, while differences
in age and body mass index (BMI, kg/m2) between older adult decedents and centenarians
were assessed using Student's t-test. Differences in concentrations of lutein among the three
groups of decedents were evaluated using one-way ANOVA, followed by pairwise compari-
sons with Bonferroni adjustments. Differences in concentrations of lutein and StARD3 level
between two regions of the brain (only decedents with both brain regions) were evaluated
using Wilcoxon signed rank test. Differences of StARD3 between brain tissues with and with-
out detectable levels of cis-lutein, as well as differences of lutein between older adult dece-
dents with normal cognitive function and Alzheimer’s disease were evaluated using
Wilcoxon rank sum test. Pearson's correlation was performed to determine correlation
between age and weight or height of infants, between age and BMI of adult decedents, and to
determine if either brain lutein concentration and StARD3 level were related to interval
between time of death and tissue storage. Pearson's correlation coefficients were also used to
determine relationship between brain lutein and StARD3 level. Partial correlation analysis
was used in multiple linear regressions. For the infant decedents, the multiple linear regres-
sion model included age, sex, and term status and for the older adults variables included age,
sex, and presence of Alzheimer’s disease as potential confounders of the relationship between
lutein and StaRD3. The significance level was set at P< 0.05. R version 3.1.1 was used for all
statistical analysis.
Lutein and StARD3
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Results
Subject Characteristics
Table 1 describes the characteristics of the infant and adult decedents. Mean age of infant dece-
dents was 95.6 days. Nine out of ten infant decedents ranged from 86 to 123 days, and one
female infant decedent was 31 days at the time of death. There were two preterm infants both
with gestational age of 36 weeks. Six out of ten infant decedents were male, and median age of
male infants was marginally greater than the median age of female infants (P = 0.067). Eight
infants were Caucasian, and two infants were African American. An infant who was the oldest
at the time of death also had the highest height of 73.7 cm and the highest body weight of 9.5
kg among infant decedents. Height, but not weight, significantly correlated with age in infant
decedents (P< 0.05). BMI was not calculated for infant decedents. Four infants died of SIDS
while the remaining six infants died of various other conditions. (S1 Table). Because brain
lutein concentration and StARD3 level were not significantly different between infants who
died of SIDS and other causes, data from two groups were combined.
There was a significant difference between mean age of older adults (range from 55 to 86
years) and mean age of centenarians (range from 98 to 105 years) (P< 0.0001). Among older
adult decedents, the youngest subject also had the lowest BMI (55 yrs, 15.3 kg/m2), and the old-
est subject also had the highest BMI (86 yrs, 33.7 kg/m2). There was a significant correlation
between age and BMI (P< 0.01). However, there was no significant correlation between age
and BMI in centenarians. BMI was not statistically different between older adults and centenar-
ians. Half of the older adults were female, while all of centenarians were female. Mean age of
older adult males was not significantly different from mean age of older adult females. Only
one older adult subject was Hispanic, while the remaining seven subjects were Caucasian.
Three subjects in the older adult group had Alzheimer’s disease, while only one centenarian
had pre-mortem Global Deterioration Rating Scale higher than 3, which is classified as demen-
tia. The remaining subjects in the centenarian group, three were classified as cognitive intact
and six were classified as mildly cognitive impaired. There were no statistically significant dif-
ferences in brain lutein concentration and StARD3 level between older adult decedents with
normal cognitive function and Alzheimer’s disease; hence all data were analyzed together.
Details of cause of death are available for older adults but not for centenarians (S2 Table).
Details of presence of cancer, diabetes, and cardiovascular disease are available for centenarians
(S3 Table). There were no significant relationships between post mortem interval (time of
death to storage) and either brain lutein concentration or brain StARD3 level in both infants
and older adults. Post mortem interval data was not available for centenarians.
Brain Lutein Concentration
Mean concentrations of trans-lutein in brain tissues from each age group are shown in
Table 2. Trans-lutein was detected in all brain tissues (range: 3.9 to 132.5 pmol/g in infants,
23.6 to 97.0 pmol/g in older adults, 12.9 to 258.1 pmol/g in centenarians). On the contrary,
only five of 17 infant brain tissues, seven of 16 older adults tissues, and four or 15 centenarian
tissues had detectable levels of cis-lutein. Both preterm infant decedents in this study had no
detectable level of cis-lutein. Among brain tissues with detectable cis-lutein (ranging from 2.4
to 12.9 pmol/g), its concentration accounted for 3–9% of total lutein in infants, 4–10% in older
adults, and 4–8% in centenarians (data not shown).
Among the three age groups overall means of trans-lutein concentration not sharing a com-
mon superscript are significantly different at P< 0.05 (univariate ANOVA with Bonferroni
adjustment for multiple comparisons).
Lutein and StARD3
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Table 1. Subject characteristicsa.
Infantsb (n = 10) Older adultsb (n = 8) Centenariansb (n = 10)
Agec
Mean (SEM) 95.6 (8.0) 76.4 (3.3) 100.2 (0.7)
Median 99.0 79.5 100.0
Range 31–123 55–86 98–105
Preterm, n (%) 2 (20%) NA NA
Sex
Females, n (%) 4 (40%) 4 (50%) 10 (100%)
Race
Caucasian, n (%) 8 (80%) 7 (87.5%) 8 (80%)
African American, n (%) 2 (20%) 0 (0%) 1 (10%)
Hispanic, n (%) 0 (0%) 1 (12.5%) 0 (0%)
Height, cm or md
Mean (SEM) 6.4 (0.4) 1.74 (0.02) 1.55 (0.02)
Median 6.1 1.73 1.57
Range 5.4–9.5 1.70–1.85 1.45–1.70
Weight, kg
Mean (SEM) 6.4 (0.4) 81.0 (5.6) 55.6 (4.5)
Median 6.1 79.4 51.3
Range 5.4–9.5 52.2–97.5 33.6–77.1
BMI, kg/m2
Mean (SEM) NA 26.86 (2.18) 22.75 (1.34)
Median 27.47 22.84
Range 15.27–33.73 16.01–29.10
Presence of disease, n (%)
Alzheimer’s disease NA 3 (37.5%) ND
MCI or dementia ND 7 (70%)
Other ND 9 (90%)
Cause of death
SIDS, n (%) 4 (40%) NA NA
Others, n (%) 6 (60%) 8 (100%)
Time interval between death and tissue collection, hours
Mean (SEM) 16.8 (1.6) 13.9 (2.4) ND
Median 17.5 11.0
Range 9–23 7–24
Brain tissue sample, n 17 16 15
Frontal cortex 10 0 9
Temporal cortex 0 0 6
Occipital cortex 0 8 0
Hippocampus 7 8 0
NA = not applicable
ND = no data available
aSee S1–S3 Tables for more information
bOne infant, one older adult, and one centenarian had no data for height and weight. One centenarian had no data for race.
cAge in days for infants, in years for older adults
dHeight in centimeters for infants, in meters for older adults
doi:10.1371/journal.pone.0155488.t001
Lutein and StARD3
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In the evaluation of each brain region separately, there were no significant differences
between concentration of trans-lutein in FC and Hipp in infants, as well as between FC and TC
in centenarians. However, the concentration of trans-lutein in OC was significantly greater
than that in Hipp in older adults (Table 2, P< 0.05). Although there were no differences
observed in concentrations of trans-lutein in Hipp between infants and older adults, and in FC
between infants and centenarians, the mean lutein concentration of all brain tissues in cente-
narians was significantly greater compared to the mean concentration in infants (P< 0.05),
and the mean value for older adults tissues was not significantly different from the these two
groups. The same observation was also true for total lutein concentrations.
Brain StARD3 Level
Level of StARD3 protein in brain tissue was reported as the intensity of the bands in western
blot analysis (Table 2). There was no significant difference between StARD3 band intensity
between FC and Hipp in infants, between OC and Hipp in older adults, and between FC and
TC in centenarians. It is noteworthy that compared to infant brain tissues with non-detectable
level of cis-lutein, infant tissues with detectable level of cis-lutein had significantly higher level
of StARD3 (P< 0.05) (data not shown). There was no such significant difference in older
adults and centenarians. Due to the nature of western blot analysis (separate runs were per-
formed), the intensity of bands cannot be compared among subject groups.
Relationship between Brain Lutein Concentration and StARD3 Level
The correlations between brain lutein concentrations in the brain and StARD3 level were ana-
lyzed in each age group. Trans-lutein concentration in the brain of infant decedents was highly
significantly related to StARD3 band intensity (r = 0.74, P< 0.001) (Fig 1A). When looked at
separately for each region of the brain, the relationship was significant in FC (r = 0.82,
P< 0.01) but not in the Hipp, perhaps due to the fewer samples from this region. Cis-lutein
also significantly correlated with StARD3 in all infant brain tissues (Fig 1B, r = 0.83, P< 0.05)
and in FC alone (r = 0.83, P< 0.01), and the significance of this correlation improved in all
infant brain tissues when data points with undetectable level of cis-lutein were excluded
(r = 0.79, P< 0.001). The correlation and significance of this relationship were also higher
when both cis and trans isomers were combined (Fig 1C, r = 0.75, P< 0.001) than when
evaluating trans-lutein alone. The relationship between total lutein and StARD3 remained
Table 2. Mean (±SEM) brain concentration of trans-lutein and StARD3 band intensity of infants, older adults, and centenarians.
Group Brain region trans-lutein (pmol/g) P value* StARD3 band intensity P value*
Infants FC (n = 10) 52.3 7± 14.95 0.938 7521.64 ± 1190.22 0.938
Hipp (n = 7) 31.93 ± 6.27 6460.07 ± 1192.44
Overall (n = 17) 43.95 ± 9.53 7084.52 ± 839.85
Older adults OC (n = 8) 71.33 ± 7.36 0.039 2212.25 ± 352.89
Hipp (n = 8) 53.87 ± 6.27 1908.13 ± 339.80
Overall (n = 16) 62.61 ± 5.18 2060.19 ± 239.87
Centenarians FC (n = 9) 99.84 ± 23.57 0.625 8457.32 ± 805.98 0.125
TC (n = 6) 94.48 ± 36.74 10887.65 ± 1695.23
Overall (n = 15) 97.70 ± 19.59 9429.45 ± 857.04
* Significant difference between two regions of brain within each subject group. Wilcoxon signed-rank test was applied for only samples available from the
same subject.
doi:10.1371/journal.pone.0155488.t002
Lutein and StARD3
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statistically significant in all infant brain tissues after adjusting for covariate age and sex
(P< 0.001), and also age, sex, and term status (preterm/full term) (P< 0.001).
In older adults, bivariate analysis showed a marginally significant relationship between
brain trans-lutein concentration and StARD3 level (r = 0.49, P = 0.053) (Fig 2A). However, the
relationships between StARD3 and cis-lutein alone (Fig 2B, r = 0.57, P< 0.05), and between
StARD3 and total lutein (Fig 2C, r = 0.51, P< 0.05) were both significant. Data from OC or
Hipp alone showed no significant relationship between lutein and StARD3. This was likely due
to the low number of samples. Furthermore, the relationship between total lutein and StARD3
remained statistically significant after adjusting for presence of Alzheimer’s disease (r = 0.64,
P< 0.05), and also after adjusting for covariates age, sex, and presence of Alzheimer’s disease
(r = 0.60, P< 0.05). No significant relationships with StARD3 were found in centenarians for
Fig 1. The relationship between trans (A), cis (B) and total (trans+cis) (C) lutein (pmol/g) and StARD3 (band intensity) in pediatric (1–4 months) decedents
(n = 10). Tissues were from the frontal cortex (n = 10) and hippocampus (n = 7).
doi:10.1371/journal.pone.0155488.g001
Fig 2. The relationship between trans (A), cis (B) and total (trans+cis) (C) lutein (pmol/g) and StARD3 (band intensity) in older adult (55–86 yrs) decedents
(n = 16). Tissues were from the occipital cortex (n = 8) and hippocampus (n = 8).
doi:10.1371/journal.pone.0155488.g002
Lutein and StARD3
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trans-lutein, cis-lutein or total lutein, (Fig 3A–3C). Excluding data points with undetectable
level of cis-lutein did not improve any relationship.
Discussion
StARD3 has been previously reported to be the specific binding protein for lutein in the retina
and likely explains its selective accumulation in the macula [5][18]. As in the macula, lutein
selectively accumulates in human brain tissue in early and later life [9–11]. This present study
is the first to report cross-sectional relationships between brain lutein concentration and
StARD3 level across the brain of three different age groups. Results from this study suggest that
the preferential accumulation of lutein in brain tissue is due to this binding protein, as indi-
cated by the significant relationship between lutein and StARD3 concentrations. However, the
strength of the relationship declined with age. The relationship was highly statistically signifi-
cant in tissues from infants, marginally significant in older adults, and not related in centenari-
ans. In infant decedents, even after adjusting for age, sex, and term status (preterm/full term),
the positive correlation between brain lutein and StARD3 remained highly significant. Based
on the observation in our previous study that preterm infants had significantly lower concen-
tration of lutein in their brain compared to term infants [9], term status was included in the
model as a potential confounder. This strong relationship, along with the preferential accumu-
lation of lutein among the carotenoids in infant brain, even with brief exposure lutein in the
diet, suggests that lutein may be important in neural development during early life.
The age-related decrease in the relationship between lutein and StARD3 may imply that
there is an age-related decrease/abnormality of StARD3 activity in the human brain. StARD3 is
involved in cholesterol transportation [6], which is an essential process for various functions in
neurons including myelination and de novo synthesis of steroids. Presence of Alzheimer's dis-
ease was included in the model for older adults based on the observation that after adjusting
for AD status, the relationship between lutein and StARD3 became significant. Presence of AD
is also a potential confounder of this relationship, though this may not reflect the reality, given
that roles of lutein and StARD3 in the brain of AD patients are poorly understood. Indeed,
three of eight older adults and seven of ten centenarian decedents had mild cognitive
Fig 3. The relationship between trans (A), cis (B) and total (trans+cis) (C) lutein (pmol/g) and StARD3 (band intensity) in very old adult (98–105 yrs)
decedents (n = 10). Tissues were from the frontal cortex (n = 9) and temporal cortex (n = 6).
doi:10.1371/journal.pone.0155488.g003
Lutein and StARD3
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impairment or dementia. Therefore, the neurodegeneration that occurs with aging may explain
the decrease in this relationship. In addition, this may also be an example of biological variabil-
ity, which is more common in human subjects as age increases. Of interest would be to explore
this relationship in cognitively intact centenarians to therefore aid in the differentiation
between extreme aging and dementia. This would aid in the generalizability of our findings.
Improvement of the correlation with StARD3 when cis- and trans-lutein were combined
compared to the trans isomer alone, together with a significant relationship between the cis iso-
mer with StARD3 in infants and older adults, suggests potential binding of cis-lutein with
StARD3. To date, there is no known report of cis-lutein binding activity of StARD3. In human
retina, StARD3 has been recognized as a trans-lutein binding protein [1][5]. However, whether
this suggests cis-lutein is important in neural development or cognitive health is still question-
able given its very low level in human brain throughout life (4–10% of total carotenoids). Fur-
ther, there appears to be a selective uptake of the trans isomer into the brain given that the cis:
trans ratio is much lower in brain compared to matched serum [4]. Also, in many brain tissues
there was an absence of cis-lutein.
Although the lutein/StARD3 relationship in brain tissue differed across the three age popu-
lations, lutein was the predominant carotenoid in all groups. The lower concentration of brain
lutein in infants compared to older adults and centenarians is expected given that infants only
have a brief exposure (<1 year) to foods rich in lutein compared to the old and oldest adults
(>50 years). Nevertheless, it should be noted that the difference is only about two-fold. These
findings further support a role for lutein in early neural development.
Although our study presents intriguing data to support a role for lutein in brain function,
this present study holds the following limitations: 1) There is no direct evidence that StARD3 is
a lutein-binding protein in human brain. However, it is likely to be, given that this protein was
detected by the same antibody previously used, and was previously identified as lutein-binding
protein in human retina [5][18]; 2) Only correlational data was presented. Therefore, it is diffi-
cult to determine whether the amount of lutein is determined by the level of StARD3, whether
lutein increases level of StARD3 expression, or if StARD3 may even serve as a confounder in a
relationship between lutein and other unknown factors; 3) The sample size in each group was
small. However, this research was largely exploratory and the literature on lutein in brain tissue
is quite new and few. Lutein’s relationships with the binding protein throughout the lifespan
may direct future work evaluating a role for lutein in cognitive function. 4) Dietary lutein data
was not available. Therefore, an examination of the possible impact of diet on these results was
not possible. 5) This study assumes StARD3 as the only lutein-binding protein in human brain
tissue, while in fact, it may not be. In human retina, although StARD3 binds specifically to
lutein, another carotenoid-binding protein tubulin serves as a major deposit site of lutein, zea-
xanthin, andmeso-zeaxanthin [5]. This was not investigated in brain tissue.
This present study expands our knowledge of the preferential uptake of lutein in human
brain tissue. Given that StARD3 is a specific deposition site of lutein in macula, its presence in
the brain may explain the preferential accumulation of lutein in this tissue. Also, given that
StARD3 is a membrane-associated protein, and lutein is also found in the membrane [19],
lutein may be able to modulate functional properties and structural features of synaptic mem-
brane, as it was shown to enhance gap junction communication between neurons [20]. As
humans cannot synthesize lutein, a better understanding of transportation and uptake of lutein
into brain may help us optimize nutritional interventions for early neural development and for
people with high risk of neurodegenerative diseases, and to the extent of improving dietary rec-
ommendations in general population. Results from this descriptive and exploratory study, war-
rant further investigation of the molecular mechanisms of brain lutein and its role in neural
development and delaying cognitive impairment.
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